INBPOTCPharmaceutical PreparationsFiscal year ends June 30
INTEGRATED BIOPHARMA INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 25, 2026
$0.18+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $5.59M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Integrated Biopharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 25, 2026 | Sep 25, 2026 | SEC EDGAR |
| Annual report | 10-K | Jun 30, 2026 | Sep 25, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 20, 2026 | Aug 20, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2026 | Jul 2, 2026 | SEC EDGAR |
| Current report | 8-K | May 8, 2026 | May 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 8, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2026 | Apr 15, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 17, 2026 | Feb 18, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2026 | Feb 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2025 | Feb 11, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 1, 2025 | Dec 1, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 10, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 28, 2025 | Oct 28, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 23, 2025 | Sep 23, 2025 | SEC EDGAR |
| Annual report | 10-K | Jun 30, 2025 | Sep 23, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 24, 2025 | Apr 24, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2025 | Apr 21, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 13, 2025 | Feb 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2024 | Feb 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2024 | Dec 2, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 28, 2024 | Oct 28, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 20, 2024 | Sep 23, 2024 | SEC EDGAR |
| Annual report | 10-K | Jun 30, 2024 | Sep 20, 2024 | SEC EDGAR |
| Current report | 8-K | May 10, 2024 | May 10, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 10, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2024 | Feb 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2023 | Feb 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 27, 2023 | Nov 27, 2023 | SEC EDGAR |
| Current report | 8-K | Nov 9, 2023 | Nov 9, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 9, 2023 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 27, 2023 | Oct 27, 2023 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2023 | Sep 15, 2023 | SEC EDGAR |
| Annual report | 10-K | Jun 30, 2023 | Sep 15, 2023 | SEC EDGAR |
| Current report | 8-K | May 11, 2023 | May 11, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2023 | May 11, 2023 | SEC EDGAR |